story of the week
Age, BMI, and HGI Help Predict Benefit and Harm From Intensive Glycemic Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Characteristics Associated With Decreased or Increased Mortality Risk From Glycemic Therapy Among Patients With Type 2 Diabetes and High Cardiovascular Risk: Machine Learning Analysis of the ACCORD Trial
Diabetes Care 2017 Dec 26;[EPub Ahead of Print], S Basu, S Raghavan, DJ Wexler, SA BerkowitzFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.